Product Program year 2025 Source: CMS Open Payments

Grafapex

Drug Hematology

NDC 59137-335-01

Open in the dashboard

General payments

$19,503

77 payments

Research payments

$62,438

2 payments

Through program year 2025, $19,503 in general payments and $62,438 in research payments were reported against Grafapex (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $19,503 77
2025 Research $62,438 2

Breakdown

Who paid General payments · program year 2025
  1. Medexus Pharma, Inc. $19,503 77 payments
Top recipients General payments · program year 2025
  1. Filippo Milano Hematology & Oncology · Seattle, WA $6,138 31% · 3 payments
  2. Mhd Monzr Al Malki Hematology · Duarte, CA $4,760 24% · 2 payments
  3. Eneida Nemecek Pediatric Hematology-Oncology · Portland, OR $2,040 10% · 1 payment
  4. Michael Eckrich Pediatric Hematology-Oncology · Madison, WI $223 1% · 3 payments
  5. Rachel Phelan Pediatric Hematology-Oncology · Milwaukee, WI $210 1% · 4 payments

The top 5 of 69 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $7,805 40% · 20 practitioners
  2. Hematology Internal Medicine $5,306 27% · 7 practitioners
  3. Pediatric Hematology-Oncology Pediatrics $5,126 27% · 28 practitioners
  4. Pediatrics $318 2% · 3 practitioners
  5. Medical Oncology Internal Medicine $313 2% · 3 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $6,407 33% · 24 recipients
  2. Washington $6,138 31% · 1 recipient
  3. Oregon $2,040 10% · 1 recipient
  4. Wisconsin $740 4% · 4 recipients
  5. Maryland $581 3% · 4 recipients

The top 5 of 22 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

77 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record